Content area

Abstract

The Metaverse has gained wide attention for being the application interface for the next generation of Internet. The potential of the Metaverse is growing, as Web 3·0 development and adoption continues to advance medicine and healthcare. We define the next generation of interoperable healthcare ecosystem in the Metaverse. We examine the existing literature regarding the Metaverse, explain the technology framework to deliver an immersive experience, along with a technical comparison of legacy and novel Metaverse platforms that are publicly released and in active use. The potential applications of different features of the Metaverse, including avatar-based meetings, immersive simulations, and social interactions are examined with different roles from patients to healthcare providers and healthcare organizations. Present challenges in the development of the Metaverse healthcare ecosystem are discussed, along with potential solutions including capabilities requiring technological innovation, use cases requiring regulatory supervision, and sound governance. This proposed concept and framework of the Metaverse could potentially redefine the traditional healthcare system and enhance digital transformation in healthcare. Similar to AI technology at the beginning of this decade, real-world development and implementation of these capabilities are relatively nascent. Further pragmatic research is needed for the development of an interoperable healthcare ecosystem in the Metaverse.

Details

Title
The next generation of healthcare ecosystem in the metaverse
Author
Li, Yong 1 ; Gunasekeran, Dinesh Visva 2 ; RaviChandran, Narrendar 3 ; Ting Fang Tan 3 ; Jasmine Chiat Ling Ong 4 ; Thirunavukarasu, Arun James 5 ; Polascik, Bryce W 6 ; Habash, Ranya 7 ; Khaderi, Khizer 8 ; Ting, Daniel SW 9 

 Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore; The Ophthalmology & Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore 
 Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore; The Ophthalmology & Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore 
 Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore 
 Department of Pharmacy, Singapore General Hospital, Singapore, Singapore 
 School of Clinical Medicine, University of Cambridge, Cambridge, UK 
 Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA 
 Bascom Palmer Eye Institute, University of Miami, Florida, USA 
 Department of Ophthalmology, Stanford University, California, USA 
 Singapore National Eye Centre, Singapore Eye Research Institute, Singapore, Singapore; The Ophthalmology & Visual Sciences Academic Clinical Programme, Duke-NUS Medical School, Singapore, Singapore; Department of Ophthalmology, Stanford University, California, USA 
Section
Review Article
Publication year
2024
Publication date
Jun 2024
Publisher
Elsevier Limited
ISSN
23194170
e-ISSN
23202890
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3205395383
Copyright
©2024. The Authors